Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket
CSIMarket
 


Astrotech Corp  (NASDAQ: ASTC)
 

ASTC's Revenue Growth by Quarter and Year

Astrotech's Revenue results by quarter and year




ASTC Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 0.91
3rd Quarter March 0.34
2nd Quarter December 0.15
1st Quarter September 0.30
FY 1.70

ASTCs Annual Revenue
Astrotech's Revenue in the fiscal year 2026 $ 0.91 millions
Astrotech's Revenue in the fiscal year 2025 $ 1.05 millions
Astrotech's Revenue in the fiscal year 2024 $ 1.66 millions
Astrotech's Revenue in the fiscal year 2023 $ 0.75 millions
Astrotech's Revenue in the fiscal year 2022 $ 0.87 millions




ASTC Revenue fourth quarter 2025 Y/Y Growth Comment
Astrotech Corp achieved in the fourth quarter 2025, above Company average Revenue surge of 315% year on year, to $ 0.91 millions.

According to the results reported in the fourth quarter 2025, Astrotech Corp achieved the best Revenue growth in Laboratory Analytical Instruments industry. While Astrotech Corp' s Revenue doubling of 315% ranks overall at the positon no. 408 in the fourth quarter 2025.




ASTC Revenue ( Y/Y Growth %) 2025
2024 2023 2022
4th Quarter June 315 % 214.29 % -82.93 % 1950 %
3rd Quarter March -35.85 % 960 % 25 % -60 %
2nd Quarter December -42.31 % -76.79 % 330.77 % -53.57 %
1st Quarter September 900 % -93.02 % 975 % -78.95 %
FY   63.75 % -37.72 % 122.67 % -

Financial Statements
Astrotech's fourth quarter 2025 Revenue $ 0.91 millions ASTC's Income Statement
Astrotech's fourth quarter 2024 Revenue $ 0.22 millions Quarterly ASTC's Income Statement


ASTC Revenue (Quarter on Quarter Growth %)

2025
2024 2023 2022
4th Quarter June 168.53 % -58.49 % 40 % 925 %
3rd Quarter March 126.67 % 103.85 % -95.54 % -84.62 %
2nd Quarter December -50 % 766.67 % 160.47 % 550 %
1st Quarter September 36.36 % -57.14 % 4.88 % 100 %
FY (Year on Year)   63.75 % -37.72 % 122.67 % -




Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #0
Healthcare Sector #105
Overall #408

Revenue Y/Y Growth Statistics
High Average Low
467.5 % 25.94 % -96.88 %
(Jun 30 2024)   (June 30. 2015)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #0
Healthcare Sector #105
Overall #408
Revenue Y/Y Growth Statistics
High Average Low
467.5 % 25.94 % -96.88 %
(Jun 30 2024)   (June 30. 2015)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Astrotech's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
20400 % 564.05 % -100 %
(Dec 31 2019)  


ASTC's IV. Quarter Q/Q Revenue Comment
Astrotech Corp achieved in the IV. Quarter 2025 below company average Revenue doubling of 168.53% quarter on quarter, to $ 0.91 millions.

Although the IV. Quarter 2025 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the IV. Quarter surge, eclipses the -58.49% growth in the IV. Quarter a year ago

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 87.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #32
Overall #87
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #2
Healthcare Sector #32
Overall #87
Revenue Q/Q Growth Statistics
High Average Low
20400 % 564.05 % -100 %
(Dec 31 2019)  


ASTC's IV. Quarter Q/Q Revenue Comment
Astrotech Corp achieved in the IV. Quarter 2025 below company average Revenue doubling of 168.53% quarter on quarter, to $ 0.91 millions.

IV. Quarter 2025 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -58.49% in the IV. Quarter a year ago.

Within Laboratory Analytical Instruments industry only one company achieved higher sequential Revenue growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 87.


Astrotech's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 1.01 $ 1.20 $ 1.31 $ 1.05 $ 0.90
Y / Y Revenue Growth (TTM) 11.63 % 186.16 % 3.06 % -36.96 % -54.94 %
Year on Year Revenue Growth Overall Ranking # 110 # 181 # 67 # 26 # 70
Seqeuential Revenue Change (TTM) -15.93 % -8.61 % 25.07 % 16.17 % 115.51 %
Seq. Revenue Growth (TTM) Overall Ranking # 408 # 1800 # 2422 # 82 # 2917


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Astrotech's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of 115.51% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Astrotech's Revenue growth from the 0.34% growth in Dec 31 2025. Despite that, Astrotech showed the highest Revenue growth, among it's peers in Laboratory Analytical Instruments industry.

In the Healthcare sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 110, from total ranking in previous quarter at 181.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 43
Overall # 110

Revenue TTM Y/Y Growth Statistics
High Average Low
467.5 %
25.94 %
-96.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 0
Sector # 105
S&P 500 # 408
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2026 period, Astrotech's cumulative twelve months Revenue were $ 1 millions, company would post below average annual Revenue growth of -96.88% year on year, if the fiscal year would end at Mar 31 2026.
A slow-down in the Astrotech's Revenue growth from the 0.34% growth in Dec 31 2025. Despite that, Astrotech showed the highest Revenue growth, among it's peers in Laboratory Analytical Instruments industry.

In the Healthcare sector 42 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 110, from total ranking in previous quarter at 181.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 0
Healthcare Sector # 43
Overall # 110

Revenue TTM Y/Y Growth Statistics
High Average Low
467.5 %
25.94 %
-96.88 %
 






Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ASTC's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bullfrog Ai Holdings Inc 547.64%$ 547.638 millions
Northwest Biotherapeutics Inc516.03%$ 516.031 millions
Vistagen Therapeutics Inc 504.92%$ 504.918 millions
Kymera Therapeutics Inc 466.40%$ 466.399 millions
Surrozen Inc 408.65%$ 408.647 millions
Regenxbio Inc 405.73%$ 405.731 millions
Insmed Inc393.78%$ 393.775 millions
Omeros Corporation387.10%$ 387.096 millions
Catheter Precision Inc 380.66%$ 380.660 millions
Macrogenics Inc 377.97%$ 377.974 millions
Vireo Growth Inc.335.47%$ 335.470 millions
Astrotech Corp315.00%$ 315.000 millions
Dianthus Therapeutics Inc 294.30%$ 294.301 millions
Miragen Therapeutics Inc 278.67%$ 278.667 millions
Alpha Cognition Inc.267.56%$ 267.556 millions
Agios Pharmaceuticals Inc 259.25%$ 259.253 millions
Omniab Inc 244.24%$ 244.239 millions
Medicinova Inc 240.60%$ 240.596 millions
Clene Inc 233.33%$ 233.333 millions
Editas Medicine Inc 232.31%$ 232.309 millions
Urogen Pharma Ltd 206.17%$ 206.174 millions
Sintx Technologies Inc 199.34%$ 199.338 millions
Arrowhead Pharmaceuticals Inc 171.02%$ 171.016 millions
Cue Biopharma Inc 166.66%$ 166.655 millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________162.99%$ 162.992 millions


About Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Astrotech Corp (CIK 1001907).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-031175
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Astrotech Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.